|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 52.46 USD | -0.25% |
|
+6.47% | +32.61% |
| 09-02 | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
| 08-26 | Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATRICURE, INC. | Other Medical Equipment, Supplies & Distribution | -0.25% | +6.47% | +32.61% | +50.88% | -31.30% | 2.68B |  | | |
- Stock Market
- Stocks
- ATRC Stock
- Charts AtriCure, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
